Persistent URL of this record https://hdl.handle.net/1887/103542
In Collections
This item can be found in the following collections:
![Effects of Fostamatinib, an Oral Spleen Tyrosine Kinase Inhibitor, in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate Results From a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Effects of Fostamatinib, an Oral Spleen Tyrosine Kinase Inhibitor, in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate Results From a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
- All authors
- Weinblatt, M.E.; Genovese, M.C.; Ho, M.; Hollis, S.; Rosiak-Jedrychowicz, K.; Kavanaugh, A.; Millson, D.S.; Leon, G.; Wang, M.; Heijde, D. van der
- Date
- 2014-12-31
- Journal
- Arthritis and Rheumatology
- Volume
- 66
- Issue
- 12
- Pages
- 3255 - 3264